BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30062702)

  • 1. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
    Iwafuchi H; Ito M
    Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow failure in childhood: central pathology review of a nationwide registry].
    Ito M
    Rinsho Ketsueki; 2017; 58(6):661-668. PubMed ID: 28679999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphological diagnosis of childhood bone marrow failure syndromes].
    Hama A
    Rinsho Ketsueki; 2022; 63(9):1035-1041. PubMed ID: 36198526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization.
    Hama A; Hasegawa D; Manabe A; Nozawa K; Narita A; Muramatsu H; Kosaka Y; Kobayashi M; Koh K; Takahashi Y; Watanabe K; Ohara A; Ito M; Kojima S
    Br J Haematol; 2022 Feb; 196(4):1031-1039. PubMed ID: 34729770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are micromegakaryocytes specific for refractory cytopenia of childhood (RCC)? A study of 38 pediatric patients with thrombocytopenia unrelated to RCC.
    Aqil B; Punia JN; Curry CV; Marcogliese AN; Elghetany MT
    Leuk Res; 2016 Aug; 47():84-7. PubMed ID: 27285854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood myelodysplastic syndrome.
    Chatterjee T; Choudhry VP
    Indian J Pediatr; 2013 Sep; 80(9):764-71. PubMed ID: 23912822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of bone marrow pathology in diagnosis and differential diagnosis of refractory cytopenia of children].
    Li ZQ; Zhu XF; Yang WY; Liu EB; Sun Q; Fang LH; Sun FJ; Yang QY; Zhang PH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1042-5. PubMed ID: 23363800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
    Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.
    Font P; Loscertales J; Soto C; Ricard P; Novas CM; Martín-Clavero E; López-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellón JM; Diez-Martin JL; Villegas A
    Ann Hematol; 2015 Apr; 94(4):565-73. PubMed ID: 25387664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow findings of childhood aplastic anemia: analyses of 140 cases by central reviewers].
    Hama A; Yoshimi A; Sakaguchi H; Doisaki S; Muramatsu H; Shimada A; Takahashi Y; Nozawa K; Ito M; Tsuchida M; Manabe A; Ohara A; Kojima S
    Rinsho Ketsueki; 2011 Aug; 52(8):653-8. PubMed ID: 21897071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.
    Verburgh E; Achten R; Louw VJ; Brusselmans C; Delforge M; Boogaerts M; Hagemeijer A; Vandenberghe P; Verhoef G
    Leukemia; 2007 Apr; 21(4):668-77. PubMed ID: 17301818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current perspective of low-grade myelodysplastic syndrome in children.
    Hasegawa D
    Int J Hematol; 2016 Apr; 103(4):360-4. PubMed ID: 26939774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of childhood aplastic anemia and myelodysplastic syndrome.
    Niemeyer CM; Baumann I
    Hematology Am Soc Hematol Educ Program; 2011; 2011():84-9. PubMed ID: 22160017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.